Clinical Trial

Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

Study acronym: FSH
Recruiting
View on ClinicalTrials.gov →
Summary
This study examines if monitoring serum Follicle Stimulation Hormone (FSH) levels can predict oocyte yield and progesterone levels, considering factors like age, baseline FSH, Antral Mullerian Hormone (AMH), antral follicle count, body weight, kidney function, and urinary FSH. The aim is to find a minimum FSH level that ensures optimal ovarian response and enables tailored FSH dosages for better outcomes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-08-26; most recent amendment 2026-06-22.
Status change: Not Yet Recruiting → Recruiting 2024-12-16
Trial Details
NCT Number NCT06572930
Lead Sponsor ART Fertility Clinics LLC
Conditions Ovarian Stimulation
Enrollment 150 participants
Start Date 2024-12-16
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-25